Novartis AG: $112M Penalties

Administrative Order imposing penalties against Novartis AG, described as a Switzerland-based “global provider of pharmaceutical and healthcare products”, for “improper activities”, including “improper payments”, “forged contracts”, and “false books and records”, involving its subsidiaries and affiliates in Greece, Singapore, South Korea, and Vietnam, before the U. S. Securities and Exchange Commission.